Ms. Dolan et al., INCREASING THE DOSE AND RATE OF ALBUNEX INFUSION LEADS TO SUPERIOR LEFT-VENTRICULAR CONTRAST EFFECT, Journal of the American Society of Echocardiography, 11(5), 1998, pp. 426-432
In routine clinical use, the efficacy of Albunex in producing clinical
ly useful opacification may be lower than in initial clinical studies.
We hypothesized that increasing either the rate of injection or amoun
t of Albunex administered would increase left ventricular opacificatio
n. Fifty adult volunteers were each injected with Albunex in five volu
me/rate combinations. Blinded reviewers evaluated left ventricular opa
cification and endocardial border delineation compared with the baseli
ne (noncontrast) echocardiogram. In addition, captured digitized image
s were analyzed with video-densitometric techniques. Injected at the h
ighest volume/rate tested (20 ml at 3.0 ml/sec), Albunex provided the
greatest improvement in left; ventricular opacification, endocardial b
order delineation, and quality of the echocardiogram. The administrati
on of Albunex caused no serious adverse events at any volume/rate regi
men tested. Our data indicate that faster injection rates and larger d
ose volumes than those currently recommended by the package insert sig
nificantly improve Albunex ultrasound contrast without compromising sa
fety.